Scientists have discovered a Life-saving drug for wu lung, which is known to be an ancient and inexpensive treatment. Hydroxychloroquine tablets are also another drug thought to be effective in treating Wuhan pneumonia. Pictured are bottles of hydroxychloroquine tablets placed on a pharmacy shelf.
More than a year after the Communist virus ravaged the world, humanity has forged ahead in the fight against the outbreak. Vaccines have been introduced in many countries around the world, though effectiveness and safety still need Time to be tested. However, recently, Canadian researchers have discovered an effective treatment against Wuhan pneumonia – colchicine tablets. It is said to be an old and inexpensive treatment drug.
According to CTV News, researchers at the Montreal Heart Institute (Canada) have discovered colchicine, an effective treatment against Wuhan pneumonia. This major scientific discovery makes colchicine the first oral drug in the world that can be used to treat patients with Wuhan pneumonia without hospitalization, i.e., a drug that can be used in the early stages of the disease to prevent it from getting worse.
Simply put, if you are unfortunate enough to be isolated at Home due to an infection with Wuhan pneumonia, you can ask your Family doctor to prescribe this inexpensive and useful oral tablet for your treatment at his discretion.
Colchicine, also known as colchicine, is a plant alkaloid present in the plant colchicine. Chinese Medicine uses colchicine-rich herbs, such as the mountain cichlid mushroom, to treat gout that has been around for a thousand years, making it an ancient and inexpensive therapeutic drug.
The randomized, double-blind, placebo-controlled study was conducted in Canada, the United States, Europe, South America and South Africa, the report said.
The research team conducted a controlled study of 4,159 patients who proved positive for new crowns by nucleic acid testing and found that oral colchicine tablets reduced hospitalizations by 25 percent, ventilator use by 50 percent and mortality by 44 percent.
The study showed that colchicine treatment was effective in preventing the “inflammatory storm” phenomenon and reducing complications associated with COVID-19. “Inflammatory storms” are responsible for the rapid deterioration of symptoms in many patients with pneumonia in Wuhan, causing sudden deterioration and even death in young patients who were previously healthy and resistant.
Dr. Jean-Claude Tardif, the team’s lead scientist, commented that this was a “major scientific discovery” and that “this is the first hope for worried Wuhan pneumonia patients who hope they will not develop complications, but who have not taken oral pills in the past to reduce their risk. “
The newspaper reported that the mechanism of death of the Wuhan virus is actually similar in principle to that of the influenza virus, and that most people who are weak and have poor resistance die because of complications caused by the viral infection. The over-the-counter oral medications that are readily available for the treatment of influenza mainly serve to reduce the risk of complications, and do not kill the virus itself.
Now that colchicine tablets, an oral medication, has been shown to be effective in reducing complications from pneumonia in Wuhan, it certainly provides patients with their first weapon in the fight against the CCP virus (also known as the new coronavirus, COVID-19), a prescription medication that Dr. Tardif believes can quickly relieve hospital beds from being full or even overloaded, and reduce the financial burden on health care.
Dr. Tardif believes that colchicine can be used immediately to treat patients with pneumonia in Wuhan.
In an interview, Dr. Tardif said, “Colchicine has been around for hundreds of years, we use it to treat gout, and it’s available in pharmacies, so any doctor reading this article tomorrow can decide whether to prescribe it.”
Representing this team of microbiologists, intensivists, statisticians, computer scientists and epidemiologists from across Quebec, Dr. Tardif concluded by saying proudly, “We are very proud of the work accomplished and it is a convincing clinical result.”
However, people who are allergic to colchicine tablets should not use this drug.
Recent Comments